FGF23 and chronic kidney disease: This approach aims to stimulate 1,25-vitamin D synthesis in a podocyte injury CKD-MBD model, potentially circumventing the defects arising from PTH receptor downregulation and elevated FGF23 levels (Yoon et al., 2023).